Correlation Between Prelude Therapeutics and MediciNova

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Prelude Therapeutics and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prelude Therapeutics and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prelude Therapeutics and MediciNova, you can compare the effects of market volatilities on Prelude Therapeutics and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prelude Therapeutics with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prelude Therapeutics and MediciNova.

Diversification Opportunities for Prelude Therapeutics and MediciNova

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Prelude and MediciNova is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Prelude Therapeutics and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Prelude Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prelude Therapeutics are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Prelude Therapeutics i.e., Prelude Therapeutics and MediciNova go up and down completely randomly.

Pair Corralation between Prelude Therapeutics and MediciNova

Given the investment horizon of 90 days Prelude Therapeutics is expected to under-perform the MediciNova. But the stock apears to be less risky and, when comparing its historical volatility, Prelude Therapeutics is 2.72 times less risky than MediciNova. The stock trades about -0.13 of its potential returns per unit of risk. The MediciNova is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  168.00  in MediciNova on September 1, 2024 and sell it today you would earn a total of  39.00  from holding MediciNova or generate 23.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Prelude Therapeutics  vs.  MediciNova

 Performance 
       Timeline  
Prelude Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prelude Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
MediciNova 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Prelude Therapeutics and MediciNova Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Prelude Therapeutics and MediciNova

The main advantage of trading using opposite Prelude Therapeutics and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prelude Therapeutics position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.
The idea behind Prelude Therapeutics and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA